VGSK Technologies Inc., the parent company of ProLung, has created a method for controlled release system for the lungs which can deliver medications into the bloodstream. Our ProLung™ system can create a tremendous opportunity to improve medical therapy in the medically underserved areas around the world. Reductions in drug costs, drug administration and mass drug delivery using a single device, are just some of the advantages of the ProLung system in improving global public health systems.

VGSK Technologies Inc

Org chart

Teams

Offices